Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
21 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/21/3137533/0/en/Cullinan-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129271/0/en/Disc-Medicine-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129044/0/en/Cullinan-Therapeutics-Provides-Corporate-Update-and-Reports-Second-Quarter-2025-Financial-Results.html
22 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-acceptance-of-abstracts-for-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302510269.html
05 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/cullinan-pens-700m-pact-bcma-bispecific-pair-another-autoimmune-t-cell-engager
04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093963/0/en/Cullinan-Therapeutics-Licenses-Rights-to-Velinotamig-a-Clinical-Stage-BCMA-Directed-Bispecific-T-Cell-Engager-from-Genrix-Bio-for-Development-in-Autoimmune-Diseases.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE